Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385066396> ?p ?o ?g. }
- W4385066396 endingPage "571" @default.
- W4385066396 startingPage "567" @default.
- W4385066396 abstract "Hepatocellular carcinoma development can be decreased by achieving and maintaining complete virological response (CVR) in chronic hepatitis B. However, it is unclear whether switching from entecavir (ETV) to tenofovir alafenamide (TAF) could achieve and maintain CVR in patients with low-level viremia (LLV; HBV DNA ≤ 3.3 log IU/mL) or occasional detectable HBV DNA during ETV treatment. Therefore, we aimed to examine whether the switching from ETV to TAF is effective in achieving CVR in patients with LLV or occasional detectable HBV DNA.This study comprised 45 patients who switched from ETV to TAF. All patients received ETV and TAF for >2 years, and the HBV DNA levels were measured every 3 months. Maintaining undetectable HBV DNA during 2-year period is defined as CVR. The primary endpoint is the CVR rate during ETV and TAF treatment.The CVR rate for each of the 2 years of ETV and TAF therapy was 33.3% (15/45) and 68.9% (31/45, P < 0.01), respectively, and the CVR rate increased by switching from ETV to TAF. In patients with occasional detectable HBV DNA during ETV treatment (22 patients), 15 achieved CVR and 7 maintained occasional detectable HBV DNA. In patients with LLV during ETV treatment (eight patients), three achieved CVR and five had occasional detectable HBV DNA.Switching from ETV to TAF increases the CVR rate in patients with LLV or occasional detectable HBV DNA and could be an alternative treatment option." @default.
- W4385066396 created "2023-07-23" @default.
- W4385066396 creator A5005158019 @default.
- W4385066396 creator A5009144885 @default.
- W4385066396 creator A5009704973 @default.
- W4385066396 creator A5013837902 @default.
- W4385066396 creator A5016894008 @default.
- W4385066396 creator A5017821248 @default.
- W4385066396 creator A5018535039 @default.
- W4385066396 creator A5024065548 @default.
- W4385066396 creator A5025671725 @default.
- W4385066396 creator A5035251227 @default.
- W4385066396 creator A5043158519 @default.
- W4385066396 creator A5045476512 @default.
- W4385066396 creator A5046141576 @default.
- W4385066396 creator A5066924600 @default.
- W4385066396 creator A5070972892 @default.
- W4385066396 creator A5071741462 @default.
- W4385066396 creator A5075049932 @default.
- W4385066396 creator A5077398626 @default.
- W4385066396 creator A5083903452 @default.
- W4385066396 creator A5085351803 @default.
- W4385066396 date "2023-07-21" @default.
- W4385066396 modified "2023-10-17" @default.
- W4385066396 title "Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B" @default.
- W4385066396 cites W2121960517 @default.
- W4385066396 cites W2123543307 @default.
- W4385066396 cites W2131674072 @default.
- W4385066396 cites W2548902797 @default.
- W4385066396 cites W2589883166 @default.
- W4385066396 cites W2591717879 @default.
- W4385066396 cites W2806018121 @default.
- W4385066396 cites W2949577656 @default.
- W4385066396 cites W2982287013 @default.
- W4385066396 cites W3001174828 @default.
- W4385066396 cites W3003419751 @default.
- W4385066396 cites W3017282191 @default.
- W4385066396 cites W3017997372 @default.
- W4385066396 cites W3028952104 @default.
- W4385066396 cites W3043529563 @default.
- W4385066396 cites W3046905428 @default.
- W4385066396 cites W3118942930 @default.
- W4385066396 cites W3122531888 @default.
- W4385066396 cites W3128646645 @default.
- W4385066396 cites W3158124388 @default.
- W4385066396 cites W4200339468 @default.
- W4385066396 cites W4206403595 @default.
- W4385066396 cites W4226397873 @default.
- W4385066396 cites W4283311873 @default.
- W4385066396 cites W4283723134 @default.
- W4385066396 cites W4286498150 @default.
- W4385066396 cites W4296260941 @default.
- W4385066396 cites W4304688651 @default.
- W4385066396 cites W4306667903 @default.
- W4385066396 cites W4313488296 @default.
- W4385066396 cites W4316928612 @default.
- W4385066396 cites W4318042614 @default.
- W4385066396 doi "https://doi.org/10.1002/jgh3.12950" @default.
- W4385066396 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37649865" @default.
- W4385066396 hasPublicationYear "2023" @default.
- W4385066396 type Work @default.
- W4385066396 citedByCount "0" @default.
- W4385066396 crossrefType "journal-article" @default.
- W4385066396 hasAuthorship W4385066396A5005158019 @default.
- W4385066396 hasAuthorship W4385066396A5009144885 @default.
- W4385066396 hasAuthorship W4385066396A5009704973 @default.
- W4385066396 hasAuthorship W4385066396A5013837902 @default.
- W4385066396 hasAuthorship W4385066396A5016894008 @default.
- W4385066396 hasAuthorship W4385066396A5017821248 @default.
- W4385066396 hasAuthorship W4385066396A5018535039 @default.
- W4385066396 hasAuthorship W4385066396A5024065548 @default.
- W4385066396 hasAuthorship W4385066396A5025671725 @default.
- W4385066396 hasAuthorship W4385066396A5035251227 @default.
- W4385066396 hasAuthorship W4385066396A5043158519 @default.
- W4385066396 hasAuthorship W4385066396A5045476512 @default.
- W4385066396 hasAuthorship W4385066396A5046141576 @default.
- W4385066396 hasAuthorship W4385066396A5066924600 @default.
- W4385066396 hasAuthorship W4385066396A5070972892 @default.
- W4385066396 hasAuthorship W4385066396A5071741462 @default.
- W4385066396 hasAuthorship W4385066396A5075049932 @default.
- W4385066396 hasAuthorship W4385066396A5077398626 @default.
- W4385066396 hasAuthorship W4385066396A5083903452 @default.
- W4385066396 hasAuthorship W4385066396A5085351803 @default.
- W4385066396 hasBestOaLocation W43850663961 @default.
- W4385066396 hasConcept C126322002 @default.
- W4385066396 hasConcept C142462285 @default.
- W4385066396 hasConcept C159047783 @default.
- W4385066396 hasConcept C189490182 @default.
- W4385066396 hasConcept C2522874641 @default.
- W4385066396 hasConcept C2776175608 @default.
- W4385066396 hasConcept C2776185481 @default.
- W4385066396 hasConcept C2777382497 @default.
- W4385066396 hasConcept C2777410769 @default.
- W4385066396 hasConcept C2777869810 @default.
- W4385066396 hasConcept C2778019345 @default.
- W4385066396 hasConcept C2780593183 @default.
- W4385066396 hasConcept C2911190787 @default.
- W4385066396 hasConcept C2993143319 @default.